The Elite Test Bank: Advanced
Practice Prescriber Mastery
2026/2027
PART 0: THE NAVIGATOR
● PART I: THE PRIMER
○ The "Welcome to the Big Leagues" Hook
○ The "Panic Button" Cheat Sheet
● PART II: THE ELITE TEST BANK
○ Questions 1–15: Foundational Syntax & Application: Texas Prescriptive
Authority, PAA Mechanics, and Core Pharmacology.
○ Questions 16–40: Professional Simulation: Clinical Operations, 2026 CMS
Billing (G2211), DEA Regulations, and Joint Commission Standards.
○ Questions 41–66: Grandmaster Synthesis: High-Stakes Multi-Variable Crises,
Legal Liability, and Advanced Pharmacotherapeutics.
PART I: THE PRIMER
The "Welcome to the Big Leagues" Hook Mastering the 2026/2027 regulatory and
pharmacological landscape separates administrative liabilities from autonomous, elite clinical
prescribers. Your ability to synthesize complex state limitations with advanced
pharmacodynamics is the ultimate metric of your professional survival and patient safety.
The "Panic Button" Cheat Sheet
● The PAA Hard Deck: You must maintain a Prescriptive Authority Agreement (PAA) with
documented monthly meetings; a physician may delegate to a maximum of 7 FTEs
outside of specific exemptions.
● The Schedule II Firewall: Texas strictly prohibits outpatient Schedule II prescribing by
APRNs; it is legally restricted to hospital admissions (>24 hours), EDs, and terminal
hospice care.
● The 90-Day & Under-2 Rules: Schedule III-V prescriptions cannot exceed 90 days total
(including refills) without a documented physician consult, and prescribing any controlled
substance to a child under 2 requires a documented consult.
● The PDMP Mandate: You must verify the Texas PMP prior to prescribing the "Fatal Four"
(opioids, benzodiazepines, barbiturates, or carisoprodol), exempting only cancer and
hospice patients.
● The 2026 Billing Edge: CMS Code G2211 applies to longitudinal visit complexity and is
fully authorized for home visits (99341-99350) as of 2026, but is strictly prohibited if
appended with Modifier 25.
PART II: THE ELITE TEST BANK
,Q1: An APRN establishes a new Prescriptive Authority Agreement (PAA) in 2026. According to
the Texas Board of Nursing and Texas Medical Board rules, which parameter dictates the
MINIMUM REQUIRED frequency and format of their quality assurance meetings? A)
Face-to-face meetings must occur daily for the first year, transitioning to monthly chart reviews
thereafter. B) Meetings must occur at least once a month, utilizing either in-person or remote
video-conferencing, and must be documented. C) The delegating physician must be on-site
10% of the APRN's clinical hours to conduct direct supervision. D) Meetings are required
quarterly, provided the APRN has over 5 years of independent clinical experience.
● The Answer: B (Meetings must occur at least once a month, utilizing either in-person or
remote video-conferencing, and must be documented.)
● Distractor Analysis:
○ A is incorrect: Face-to-face requirements were eliminated for PAAs executed after
September 2019.
○ C is incorrect: On-site percentage requirements are an outdated legacy metric from
prior legislative sessions.
○ D is incorrect: Post-2019 legislation removed experience-based tiered meeting
frequencies; monthly meetings are universally mandatory regardless of tenure.
The Mentor's Analysis: The law demands consistency, not geography. Modern PAAs focus on
the quality of communication rather than physical proximity. You must document the discussion
of patient care improvement and chart reviews monthly. Professional Intuition: Schedule these
meetings as non-negotiable patient encounters; missing one invalidates your legal cover.
Q2: A primary care APRN assesses a 45-year-old patient with severe adult-onset ADHD. The
patient requests a refill of their dextroamphetamine/amphetamine, a Schedule II controlled
substance. Which action is the MOST APPROPRIATE under Texas law? A) Write a 30-day
supply with no refills and mandate a follow-up appointment. B) Check the PDMP, consult the
delegating physician, and issue a 90-day supply. C) Refuse to prescribe the medication and
refer the patient to a psychiatrist or the delegating physician. D) Issue the prescription but
co-sign it with the delegating physician's DEA number.
● The Answer: C (Refuse to prescribe the medication and refer the patient to a psychiatrist
or the delegating physician.)
● Distractor Analysis:
○ A is incorrect: Outpatient APRNs in Texas cannot legally prescribe Schedule II
medications for ADHD.
○ B is incorrect: The 90-day rule applies to Schedules III-V, not Schedule II.
○ D is incorrect: You cannot use another provider's DEA number; this constitutes DEA
fraud.
The Mentor's Analysis: Texas operates as a Restricted Practice state. Schedule II prescribing
is a hard redline in the outpatient primary care setting. Knowing what you cannot do is as critical
as knowing what you can. Bypass the temptation to help the patient at the expense of your
license.
Q3: An APRN is managing a 42-year-old patient on a Schedule IV controlled substance for
generalized anxiety. The patient requests a 6-month prescription to avoid frequent clinic visits.
What is the MAXIMUM duration the APRN can authorize before a physician consultation is
legally required? A) 30 days B) 90 days C) 180 days D) 365 days
● The Answer: B (90 days)
● Distractor Analysis:
○ A is incorrect: 30 days is a common clinical standard for initial opioid fills, but Texas
law allows up to 90 days for Schedule III-V.
, ○ C is incorrect: This exceeds the statutory limit set by the Texas Occupations Code
157.0511.
○ D is incorrect: A one-year supply for controlled substances is strictly prohibited.
The Mentor's Analysis: The 90-day ceiling is absolute. This includes the initial fill plus all refills.
If the patient requires day 91, you must formally consult your delegating physician and
document that exact consultation in the chart prior to authorizing further therapy.
Q4: A 16-month-old toddler presents to the outpatient pediatric clinic with severe viral stomatitis.
The APRN wishes to prescribe a low-dose liquid Schedule IV analgesic. What must the APRN
do FIRST before issuing the prescription? A) Obtain informed consent from both parents. B)
Verify the child's weight to calculate the exact milligram-per-kilogram dosage. C) Consult the
delegating physician and document the consultation in the medical record. D) Verify the parents'
history in the Prescription Drug Monitoring Program (PDMP).
● The Answer: C (Consult the delegating physician and document the consultation in the
medical record.)
● Distractor Analysis:
○ A is incorrect: While general consent is needed for treatment, it does not supersede
the strict statutory requirement for prescribing to infants.
○ B is incorrect: Weight-based dosing is a clinical given, but the legal barrier takes
precedence. * D is incorrect: PDMP checks are for the patient receiving the drug,
not primarily the parents.
The Mentor's Analysis: Texas Occupations Code 157.0511 places a protective firewall around
children under 2 years of age. Any controlled substance prescription for this population requires
documented physician consultation. Failure to document this equates to practicing medicine
without a license.
Q5: An APRN is preparing to prescribe carisoprodol (Soma) for an acute musculoskeletal injury.
Under the Texas Health and Safety Code, what is the MANDATORY action required prior to
issuing this specific prescription? A) Perform a baseline urine drug screen. B) Check the Texas
Prescription Monitoring Program (PDMP). C) Limit the prescription to a 10-day supply. D) Obtain
a signed pain management contract.
● The Answer: B (Check the Texas Prescription Monitoring Program (PDMP).)
● Distractor Analysis:
○ A is incorrect: UDS is best practice in chronic pain, but not legally mandated for an
acute injury muscle relaxant.
○ C is incorrect: While opioids for acute pain have a 10-day limit, carisoprodol does
not have this specific statutory day limit, though it requires PMP verification.
○ D is incorrect: Pain contracts are for chronic management, not acute injury
prescribing.
The Mentor's Analysis: The state actively monitors compliance with the PMP mandate.
Opioids, benzodiazepines, barbiturates, and carisoprodol are the "Fatal Four" that trigger
mandatory database queries. Checking the PMP is not a suggestion; it is an auditable legal
requirement.
Q6: A 68-year-old patient with terminal pancreatic cancer, actively enrolled in a certified hospice
program, requires an escalation in their Schedule II opioid pain regimen. The APRN is the
primary provider managing the hospice care plan. Can the APRN legally issue this prescription
in Texas? A) No, APRNs cannot prescribe Schedule II medications under any circumstances in
Texas. B) Yes, but only if the delegating physician co-signs the prescription within 24 hours. C)
Yes, Schedule II prescribing is permitted for terminally ill patients receiving qualified hospice
care. D) No, the prescription must be routed through the hospital inpatient pharmacy exclusively.
Practice Prescriber Mastery
2026/2027
PART 0: THE NAVIGATOR
● PART I: THE PRIMER
○ The "Welcome to the Big Leagues" Hook
○ The "Panic Button" Cheat Sheet
● PART II: THE ELITE TEST BANK
○ Questions 1–15: Foundational Syntax & Application: Texas Prescriptive
Authority, PAA Mechanics, and Core Pharmacology.
○ Questions 16–40: Professional Simulation: Clinical Operations, 2026 CMS
Billing (G2211), DEA Regulations, and Joint Commission Standards.
○ Questions 41–66: Grandmaster Synthesis: High-Stakes Multi-Variable Crises,
Legal Liability, and Advanced Pharmacotherapeutics.
PART I: THE PRIMER
The "Welcome to the Big Leagues" Hook Mastering the 2026/2027 regulatory and
pharmacological landscape separates administrative liabilities from autonomous, elite clinical
prescribers. Your ability to synthesize complex state limitations with advanced
pharmacodynamics is the ultimate metric of your professional survival and patient safety.
The "Panic Button" Cheat Sheet
● The PAA Hard Deck: You must maintain a Prescriptive Authority Agreement (PAA) with
documented monthly meetings; a physician may delegate to a maximum of 7 FTEs
outside of specific exemptions.
● The Schedule II Firewall: Texas strictly prohibits outpatient Schedule II prescribing by
APRNs; it is legally restricted to hospital admissions (>24 hours), EDs, and terminal
hospice care.
● The 90-Day & Under-2 Rules: Schedule III-V prescriptions cannot exceed 90 days total
(including refills) without a documented physician consult, and prescribing any controlled
substance to a child under 2 requires a documented consult.
● The PDMP Mandate: You must verify the Texas PMP prior to prescribing the "Fatal Four"
(opioids, benzodiazepines, barbiturates, or carisoprodol), exempting only cancer and
hospice patients.
● The 2026 Billing Edge: CMS Code G2211 applies to longitudinal visit complexity and is
fully authorized for home visits (99341-99350) as of 2026, but is strictly prohibited if
appended with Modifier 25.
PART II: THE ELITE TEST BANK
,Q1: An APRN establishes a new Prescriptive Authority Agreement (PAA) in 2026. According to
the Texas Board of Nursing and Texas Medical Board rules, which parameter dictates the
MINIMUM REQUIRED frequency and format of their quality assurance meetings? A)
Face-to-face meetings must occur daily for the first year, transitioning to monthly chart reviews
thereafter. B) Meetings must occur at least once a month, utilizing either in-person or remote
video-conferencing, and must be documented. C) The delegating physician must be on-site
10% of the APRN's clinical hours to conduct direct supervision. D) Meetings are required
quarterly, provided the APRN has over 5 years of independent clinical experience.
● The Answer: B (Meetings must occur at least once a month, utilizing either in-person or
remote video-conferencing, and must be documented.)
● Distractor Analysis:
○ A is incorrect: Face-to-face requirements were eliminated for PAAs executed after
September 2019.
○ C is incorrect: On-site percentage requirements are an outdated legacy metric from
prior legislative sessions.
○ D is incorrect: Post-2019 legislation removed experience-based tiered meeting
frequencies; monthly meetings are universally mandatory regardless of tenure.
The Mentor's Analysis: The law demands consistency, not geography. Modern PAAs focus on
the quality of communication rather than physical proximity. You must document the discussion
of patient care improvement and chart reviews monthly. Professional Intuition: Schedule these
meetings as non-negotiable patient encounters; missing one invalidates your legal cover.
Q2: A primary care APRN assesses a 45-year-old patient with severe adult-onset ADHD. The
patient requests a refill of their dextroamphetamine/amphetamine, a Schedule II controlled
substance. Which action is the MOST APPROPRIATE under Texas law? A) Write a 30-day
supply with no refills and mandate a follow-up appointment. B) Check the PDMP, consult the
delegating physician, and issue a 90-day supply. C) Refuse to prescribe the medication and
refer the patient to a psychiatrist or the delegating physician. D) Issue the prescription but
co-sign it with the delegating physician's DEA number.
● The Answer: C (Refuse to prescribe the medication and refer the patient to a psychiatrist
or the delegating physician.)
● Distractor Analysis:
○ A is incorrect: Outpatient APRNs in Texas cannot legally prescribe Schedule II
medications for ADHD.
○ B is incorrect: The 90-day rule applies to Schedules III-V, not Schedule II.
○ D is incorrect: You cannot use another provider's DEA number; this constitutes DEA
fraud.
The Mentor's Analysis: Texas operates as a Restricted Practice state. Schedule II prescribing
is a hard redline in the outpatient primary care setting. Knowing what you cannot do is as critical
as knowing what you can. Bypass the temptation to help the patient at the expense of your
license.
Q3: An APRN is managing a 42-year-old patient on a Schedule IV controlled substance for
generalized anxiety. The patient requests a 6-month prescription to avoid frequent clinic visits.
What is the MAXIMUM duration the APRN can authorize before a physician consultation is
legally required? A) 30 days B) 90 days C) 180 days D) 365 days
● The Answer: B (90 days)
● Distractor Analysis:
○ A is incorrect: 30 days is a common clinical standard for initial opioid fills, but Texas
law allows up to 90 days for Schedule III-V.
, ○ C is incorrect: This exceeds the statutory limit set by the Texas Occupations Code
157.0511.
○ D is incorrect: A one-year supply for controlled substances is strictly prohibited.
The Mentor's Analysis: The 90-day ceiling is absolute. This includes the initial fill plus all refills.
If the patient requires day 91, you must formally consult your delegating physician and
document that exact consultation in the chart prior to authorizing further therapy.
Q4: A 16-month-old toddler presents to the outpatient pediatric clinic with severe viral stomatitis.
The APRN wishes to prescribe a low-dose liquid Schedule IV analgesic. What must the APRN
do FIRST before issuing the prescription? A) Obtain informed consent from both parents. B)
Verify the child's weight to calculate the exact milligram-per-kilogram dosage. C) Consult the
delegating physician and document the consultation in the medical record. D) Verify the parents'
history in the Prescription Drug Monitoring Program (PDMP).
● The Answer: C (Consult the delegating physician and document the consultation in the
medical record.)
● Distractor Analysis:
○ A is incorrect: While general consent is needed for treatment, it does not supersede
the strict statutory requirement for prescribing to infants.
○ B is incorrect: Weight-based dosing is a clinical given, but the legal barrier takes
precedence. * D is incorrect: PDMP checks are for the patient receiving the drug,
not primarily the parents.
The Mentor's Analysis: Texas Occupations Code 157.0511 places a protective firewall around
children under 2 years of age. Any controlled substance prescription for this population requires
documented physician consultation. Failure to document this equates to practicing medicine
without a license.
Q5: An APRN is preparing to prescribe carisoprodol (Soma) for an acute musculoskeletal injury.
Under the Texas Health and Safety Code, what is the MANDATORY action required prior to
issuing this specific prescription? A) Perform a baseline urine drug screen. B) Check the Texas
Prescription Monitoring Program (PDMP). C) Limit the prescription to a 10-day supply. D) Obtain
a signed pain management contract.
● The Answer: B (Check the Texas Prescription Monitoring Program (PDMP).)
● Distractor Analysis:
○ A is incorrect: UDS is best practice in chronic pain, but not legally mandated for an
acute injury muscle relaxant.
○ C is incorrect: While opioids for acute pain have a 10-day limit, carisoprodol does
not have this specific statutory day limit, though it requires PMP verification.
○ D is incorrect: Pain contracts are for chronic management, not acute injury
prescribing.
The Mentor's Analysis: The state actively monitors compliance with the PMP mandate.
Opioids, benzodiazepines, barbiturates, and carisoprodol are the "Fatal Four" that trigger
mandatory database queries. Checking the PMP is not a suggestion; it is an auditable legal
requirement.
Q6: A 68-year-old patient with terminal pancreatic cancer, actively enrolled in a certified hospice
program, requires an escalation in their Schedule II opioid pain regimen. The APRN is the
primary provider managing the hospice care plan. Can the APRN legally issue this prescription
in Texas? A) No, APRNs cannot prescribe Schedule II medications under any circumstances in
Texas. B) Yes, but only if the delegating physician co-signs the prescription within 24 hours. C)
Yes, Schedule II prescribing is permitted for terminally ill patients receiving qualified hospice
care. D) No, the prescription must be routed through the hospital inpatient pharmacy exclusively.
